FindTrial
Sign In

Effect of a polyherbal Ayurvedic formulation in subjects with type 2 diabetes

Standardization and Validation of Polyherbal formulation and its Therapeutic role in Type-2 Diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004490
Enrollment
172
Registered
2014-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type-2 Diabetes Mellitus

Interventions

Intervention1: Polyherbal formulation: 500 mg to 3 g/day depending on the blood sugar of the patients of the patients on subsequent visits (every week) till six months. Control Intervention1: Metformi

Sponsors

King Georges Medical University
Lead Sponsor
HMPD CSIRCentral Institute of Medicinal and Aromatic Plants
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed diabetics as per criteria recommended by Standards of Medical Care in Diabetes-2011 by American Diabetes Association. 2. Subjects not taking medication in any form.

Exclusion criteria

Exclusion criteria: 1. Subjects having contraindication of metformin and serum creatinine level > 1.2 mg/dl 2. Subject having Type-1 diabetes severe cardiovascular disorders, pregnancy, hypertension and obvious noncompliance

Design outcomes

Primary

MeasureTime frame
Blood sugar (Fasting and post prandial), HbA1cTimepoint: Baseine and every week till 6 months—

Secondary

MeasureTime frame
1. Lipid profile:Total cholesterol, Triglyceride, HDL, LDL, VLDL. 2. Liver Profile: AST, ALT, ALP, Bilirubin. 3. Kidney Profile: Creatnine, BUN, uric acidTimepoint: baseline, 3rd month, 6 month—

Countries

India

Contacts

Public ContactHarshika Awasthi

CSIR-Central Institute of Medicinal and Aromatic Plants

manidayanandan@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 17, 2026